ethinylestradiol - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
ISABELLE TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack
AUST R: 180561
Active ingredients:
drospirenone
ethinylestradiol

Dosage form:
Tablet

Sponsor:
Lupin Australia Pty Limited

Phone:
03 9809 7900

From
08 Feb 2024
to
19 Apr 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternative generic products are available.

Bella ethinylestradiol/drospirenone 20 microgram/3 mg tablet blister pack
AUST R: 196255
Active ingredients:
drospirenone
ethinylestradiol

Dosage form:
Tablet, film coated

Sponsor:
Lupin Australia Pty Limited

Phone:
03 9809 7900

From
01 Apr 2024
to
01 Aug 2024

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
Another pack size is available. Alternative generic products are available.

BREVINOR-1 28 DAY tablet blister pack
AUST R: 62134
Active ingredients:
ethinylestradiol
norethisterone

Dosage form:
Tablet, uncoated

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

Deletion from market:
19 Apr 2023

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

LENEST 20 ED levonorgestrel/ethinylestradiol 100 microgram/20 microgram tablet blister composite pack
AUST R: 219146
Active ingredients:
ethinylestradiol
levonorgestrel

Dosage form:
Tablet

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

Deletion from market:
31 Jan 2024

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Alternative generic products are available.

TRIPHASIL ethinylestradiol/levonorgestrel tablet blister pack
AUST R: 10419
Active ingredients:
ethinylestradiol
levonorgestrel

Dosage form:
Tablet, sugar coated

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

Deletion from market:
01 Jun 2023

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Other brands are available.